Monday, 2 September 2019

Injection may become alternative anti-cholesterol medication for millions of patients

A global trial led by Imperial College London has shown the 'gene-silencing' drug inclisiran to reduce 'bad' LDL cholesterol by 50 per cent. Injection would be given one every six months.

from News | Mail Online https://ift.tt/2zLZNZG

No comments:

Post a Comment

Pakistan seeks collaboration with SCO Trade and Economic Platform

Pakistan seeks collaboration with the SCO Trade and Economic Platform, Gwadar Pro reported on Friday. A Pakistani delegation led by Ali Huss...